GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,420,000 | -21.2% | 147,271 | -19.4% | 0.03% | -31.6% |
| Q3 2020 | $6,878,000 | -6.8% | 182,744 | +1.0% | 0.04% | -13.6% |
| Q2 2020 | $7,382,000 | +6.9% | 180,966 | -0.7% | 0.04% | -6.4% |
| Q1 2020 | $6,907,000 | -49.1% | 182,302 | -36.9% | 0.05% | -30.9% |
| Q4 2019 | $13,569,000 | -25.8% | 288,756 | -32.6% | 0.07% | -29.9% |
| Q3 2019 | $18,285,000 | +2.2% | 428,412 | -4.1% | 0.10% | +1.0% |
| Q2 2019 | $17,884,000 | -14.1% | 446,883 | -10.3% | 0.10% | -15.8% |
| Q1 2019 | $20,808,000 | +1.5% | 497,924 | -7.2% | 0.11% | -5.0% |
| Q4 2018 | $20,493,000 | +18.8% | 536,336 | +24.9% | 0.12% | +39.5% |
| Q3 2018 | $17,244,000 | +132.8% | 429,279 | +133.6% | 0.09% | +126.3% |
| Q2 2018 | $7,406,000 | +0.2% | 183,730 | -2.9% | 0.04% | 0.0% |
| Q1 2018 | $7,389,000 | +5.4% | 189,130 | -4.3% | 0.04% | +8.6% |
| Q4 2017 | $7,013,000 | -11.0% | 197,723 | +1.9% | 0.04% | -14.6% |
| Q3 2017 | $7,876,000 | -3.9% | 193,983 | +2.1% | 0.04% | -6.8% |
| Q2 2017 | $8,195,000 | +2.3% | 190,052 | 0.0% | 0.04% | -2.2% |
| Q1 2017 | $8,013,000 | +37.5% | 190,052 | +25.6% | 0.04% | +32.4% |
| Q4 2016 | $5,827,000 | -10.7% | 151,307 | 0.0% | 0.03% | -15.0% |
| Q3 2016 | $6,526,000 | -0.5% | 151,307 | 0.0% | 0.04% | -2.4% |
| Q2 2016 | $6,558,000 | +6.9% | 151,307 | 0.0% | 0.04% | +5.1% |
| Q1 2016 | $6,135,000 | -5.0% | 151,307 | -5.5% | 0.04% | -9.3% |
| Q4 2015 | $6,457,000 | -0.8% | 160,031 | -5.5% | 0.04% | -4.4% |
| Q3 2015 | $6,512,000 | -7.7% | 169,372 | 0.0% | 0.04% | -4.3% |
| Q2 2015 | $7,054,000 | +63.0% | 169,372 | +80.6% | 0.05% | +56.7% |
| Q1 2015 | $4,328,000 | +87.4% | 93,778 | +73.5% | 0.03% | +76.5% |
| Q4 2014 | $2,310,000 | +237.2% | 54,042 | +262.6% | 0.02% | +240.0% |
| Q3 2014 | $685,000 | -93.2% | 14,902 | -92.1% | 0.01% | -93.8% |
| Q2 2014 | $10,142,000 | -0.6% | 189,641 | -0.7% | 0.08% | -8.0% |
| Q1 2014 | $10,204,000 | +1553.8% | 190,984 | +1552.0% | 0.09% | +1350.0% |
| Q4 2013 | $617,000 | +6.4% | 11,561 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $580,000 | +21.3% | 11,561 | +20.9% | 0.01% | +20.0% |
| Q2 2013 | $478,000 | – | 9,561 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |